Procept Biorobotics Earnings

Procept Biorobotics’s revenue jumped 55.28% since last year same period to $69.16Mn in the Q1 2025. On a quarterly growth basis, Procept Biorobotics has generated 1.36% jump in its revenue since last 3-months.

Procept Biorobotics’s net profit jumped 4.7% since last year same period to $-24.74Mn in the Q1 2025. On a quarterly growth basis, Procept Biorobotics has generated -31.19% fall in its net profits since last 3-months.

Procept Biorobotics’s net profit margin jumped 38.63% since last year same period to -35.77% in the Q1 2025. On a quarterly growth basis, Procept Biorobotics has generated -29.43% fall in its net profit margins since last 3-months.

Procept Biorobotics’s earning per share (EPS) estimates for the current quarter stand at -0.49 - a -44.5% fall from last quarter’s estimates.

Procept Biorobotics’s earning per share (EPS) estimates for the current year stand at -0.49.

Procept Biorobotics’s earning per share (EPS) jumped 11.76% since last year same period to -0.45 in the Q1 2025. This indicates that the Procept Biorobotics has generated 11.76% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Procept Biorobotics’s return on assets (ROA) stands at -0.13.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Procept Biorobotics’s return on equity (ROE) stands at -0.28.